Moonlake Immunotherapeutics Stock Today

MLTX Stock  USD 54.31  0.81  1.51%   

Performance

6 of 100

 
Weak
 
Strong
Modest

Odds Of Distress

Less than 26

 
High
 
Low
Below Average
MoonLake Immunotherapeuti is trading at 54.31 as of the 7th of December 2024; that is 1.51 percent up since the beginning of the trading day. The stock's open price was 53.5. MoonLake Immunotherapeuti has about a 26 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 7th of November 2024 and ending today, the 7th of December 2024. Click here to learn more.
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland. Moonlake Immunotherapeuti is traded on NASDAQ Exchange in the United States. The company has 63.06 M outstanding shares of which 8 M shares are now shorted by private and institutional investors with about 36.06 trading days to cover. More on MoonLake Immunotherapeutics

Moving against MoonLake Stock

  0.42OCX OncoCyte CorpPairCorr
  0.4LPCN LipocinePairCorr
  0.32PFE Pfizer Inc Fiscal Year End 4th of February 2025 PairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

MoonLake Stock Highlights

Old NameMULTIMATRIX
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Financial Strength
MoonLake Immunotherapeutics (MLTX) is traded on NASDAQ Exchange in USA. It is located in Dorfstrasse 29, Zug, Switzerland, 6300 and employs 50 people. MoonLake Immunotherapeuti is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.37 B. MoonLake Immunotherapeuti conducts business under Biotechnology sector and is part of Health Care industry. The entity has 63.06 M outstanding shares of which 8 M shares are now shorted by private and institutional investors with about 36.06 trading days to cover. MoonLake Immunotherapeutics currently holds about 92.71 M in cash with (42.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.51.
Check MoonLake Immunotherapeuti Probability Of Bankruptcy
Ownership Allocation
MoonLake Immunotherapeuti maintains a total of 63.06 Million outstanding shares. The majority of MoonLake Immunotherapeuti outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in MoonLake Immunotherapeutics to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in MoonLake Immunotherapeuti. Please pay attention to any change in the institutional holdings of MoonLake Immunotherapeuti as this could imply that something significant has changed or is about to change at the company. Also note that almost eight million four hundred twenty-five thousand three hundred thirty-seven invesors are currently shorting MoonLake Immunotherapeuti expressing very little confidence in its future performance.
Check MoonLake Ownership Details

MoonLake Immunotherapeuti Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. MoonLake Immunotherapeuti market risk premium is the additional return an investor will receive from holding MoonLake Immunotherapeuti long position in a well-diversified portfolio.

MoonLake Stock Against Markets

MoonLake Immunotherapeuti Corporate Management

Additional Tools for MoonLake Stock Analysis

When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.